AbbVie posts weak sales of newer drugs as Humira faces fresh competition, shares fall
Go back to AbbVie posts weak sales of newer drugs as Humira faces fresh competition, shares fall| AbbVie (NYSE: ABBV) | Delayed: 232.88 +2.87 (1.25%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $230.01 | 52 Week High | $68.12 | |||
| Open | $232.97 | 52 Week Low | $50.71 | |||
| Day High | $234.30 | P/E | 50.52 | |||
| Day Low | $231.30 | EPS | $4.61 | |||
| Volume | 1,211,786 | |||||
